Patents by Inventor Chun-Fang Xu

Chun-Fang Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods Of Administration And Treatment
    Publication number: 20120232102
    Abstract: The present invention is directed to methods of administering pazopanib or pharmaceutically acceptable salts or solvates thereof as well as methods of treating cancer and age-related macular degeneration in patients in need thereof.
    Type: Application
    Filed: September 29, 2010
    Publication date: September 13, 2012
    Inventor: Chun-fang Xu
  • TREATMENT METHOD
    Publication number: 20120165354
    Abstract: The present invention relates to methods of treating age-related macular degeneration in a patient by administration of pazopanib or pharmaceutically acceptable salts or solvates thereof.
    Type: Application
    Filed: July 16, 2010
    Publication date: June 28, 2012
    Applicant: GLAXO WELLCOME MANUFACTURING PTE LTD.
    Inventors: Megan M. McLaughlin, John Irving Wurzelmann, Chun-Fang Xu
  • Gene polymorphisms and response to treatment
    Publication number: 20030100479
    Abstract: Correlations between polymorphisms in various genes, and a subject's phenotypic response to treatment with a norepinephrine reuptake inhibitor are described. Methods of screening subjects to aid in the medical treatment of obesity are presented.
    Type: Application
    Filed: August 7, 2002
    Publication date: May 29, 2003
    Inventors: David J. Dow, Benjamin Duncan, Arlene R. Hughes, Penelope Manasco, Sreekumar G. Pillai, Theodre C. Spaulding, Colin F. Spraggs, Michael Stubbins, Chun-Fang Xu